Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.69442 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.78835 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.79046 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.38545 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.73031 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.84366 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.79379 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.76476 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.78838 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.86327 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.77213 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.76649 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.039 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.83439 | 64 |